Research Group GC12 Clinical and Epidemiological Research in Primary Care, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
Department of Preventive Medicine and Public Health, University of Seville, Seville, Spain.
Front Public Health. 2023 Mar 13;11:1151225. doi: 10.3389/fpubh.2023.1151225. eCollection 2023.
Although population screening has improved the early diagnosis of colorectal cancer (CRC), most cases are diagnosed in symptomatic patients. This study aimed to estimate the prevalence and evolution over time of uptake patterns to fecal immunochemical test (FIT) as a screening test for CRC among individuals aged 50-69 in Spain, and to determine the predictive factors for uptake patterns to this type of screening based on sociodemographic, health, and lifestyle characteristics.
A cross-sectional study with 14,163 individuals from the 2017 Spanish National Health Survey and the 2020 European Health Survey was performed, including as the main variable uptake pattern to FIT screening within the last 2 years, with which we analyzed sociodemographic factors, health status and lifestyle habits.
38.01% of participants had undergone FIT in the previous 2 years, and from 2017 to 2020, a significant increase in the uptake rate for CRC was observed (2017: 32.35%, 2020: 43.92%, < 0.001). The positive predictors to FIT uptake pattern included factors such as being between 57 and 69 years, having a higher educational level or a higher social class, having at least one chronic illness, frequent contact with the primary care physician, alcohol consumption and physical activity, while immigration and smoking habit were negative predictors.
In Spain, although the evolution of FIT uptake pattern over time is positive, the prevalence of FIT uptake is still low (38.01%), not reaching the level considered as acceptable in the European guidelines. Moreover, there are disparities in CRC screening uptake among individuals.
尽管人群筛查提高了结直肠癌(CRC)的早期诊断率,但大多数病例仍是在有症状的患者中诊断出来的。本研究旨在评估西班牙 50-69 岁人群接受粪便免疫化学检测(FIT)筛查结直肠癌的模式的流行率及其随时间的演变,并根据社会人口学、健康和生活方式特征确定这种筛查方式的接受模式的预测因素。
对 2017 年西班牙国家健康调查和 2020 年欧洲健康调查中的 14163 名个体进行了横断面研究,主要变量是过去 2 年内接受 FIT 筛查的模式,我们分析了社会人口学因素、健康状况和生活方式习惯。
38.01%的参与者在过去 2 年内接受过 FIT 筛查,并且 2017 年至 2020 年间,CRC 的接受率显著增加(2017 年:32.35%,2020 年:43.92%,<0.001)。FIT 接受模式的阳性预测因素包括 57-69 岁之间、教育程度或社会阶层较高、至少患有一种慢性病、经常与初级保健医生接触、饮酒和体育活动等因素,而移民和吸烟习惯是负面预测因素。
尽管 FIT 接受模式随时间的演变是积极的,但西班牙 FIT 接受率仍然较低(38.01%),尚未达到欧洲指南所认为的可接受水平。此外,CRC 筛查的接受率在个体之间存在差异。